CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 171 enrolled
Drug / intervention
Overall satisfaction questionnaires of home use of Nivestimother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02956967
NCT02956967N/ACompleted
CompareCT.gov

Home Administration Of Nivestim(tm) In The Primary Prophylaxis Of Chemotherapy- Induced Febrile Neutropenia Non-interventional, Observational, Prospective Study Short Name: Home Short Name: Home

Pfizer·observational·Posted Nov 7, 2016·Updated Feb 11, 2019

In Brief

An observational study evaluating Overall satisfaction questionnaires of home use of Nivestim for Non-Interventional Study. Completed, enrolled 171 participants across 28 sites.

Detailed Summary

Non-interventional, non-comparative, national, multi-site, single-arm prospective observational study to investigate home administration of Nivestim in the primary prophylaxis of chemotherapy-Induced febrile neutropenia

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsNon-Interventional Study
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedNov 7, 2016
Enrollment StartSep 23, 2015
Primary CompletionDec 12, 2016
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 9.7 years ago

Interventions

Overall satisfaction questionnaires of home use of Nivestimother